Is the price fair?
What CNC's price assumes
Today's price asks for −20% free cash flow growth a year; over the last three years Centene Corporation delivered 5.4%, less than the record.
0.08
Price / sales · no P/E: the last twelve months did not end in a profit
- Free cash flow yield
- 30%
Free cash flow yield · Healthcare Plans median 6.5%
- Growth the price implies
- −20%
Growth the price implies · The price pays for −20% free cash flow growth a year for a decade; the business has delivered +5.4% a year over the last three.
- Price / book
- 0.76
Price / book · as of 2026-Q1
Details›
- Price / book2026-Q1
- 0.76
- EV / EBIToperating margin −2.8%: the multiple describes the denominator
- not meaningful
- EV / sales2026-Q1
- 0.06
- Free cash flow, trailing twelve months
- $8.95B
- Market capitalisation
- $30.1B
- 3-year revenue growth
- +11%
- 3-year free cash flow growth
- +5.4%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Healthcare Plans
Ranks #3 of 11 by Smart Score